# Safety of Bifidobacterium Breve PS1 for Infants

> **NCT05973812** · NA · COMPLETED · sponsor: **Universidad Complutense de Madrid** · enrollment: 80 (actual)

## Conditions studied

- Infant Development
- Safety Issues

## Interventions

- **DIETARY_SUPPLEMENT:** Infant formula supplemented with Bifidobacterium breve PS1
- **DIETARY_SUPPLEMENT:** Infant formula NOT supplemented with Bifidobacterium breve PS1

## Key facts

- **NCT ID:** NCT05973812
- **Lead sponsor:** Universidad Complutense de Madrid
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-12
- **Primary completion:** 2014-07-29
- **Final completion:** 2015-03-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05973812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05973812, "Safety of Bifidobacterium Breve PS1 for Infants". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05973812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*